Advertisement

Topics

Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10

2014-07-24 14:36:46 | BioPortfolio

Summary

The purpose of this study is to assess the safety of lofexidine in the treatment of opiate-dependent individuals.

Study Design

Masking: Open Label, Primary Purpose: Treatment

Conditions

Opioid-Related Disorders

Intervention

Lofexidine

Location

Friends Research Institute
Los Angeles
California
United States
90025

Status

Completed

Source

National Institute on Drug Abuse (NIDA)

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-24T14:36:46-0400

Clinical Trials [1276 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to all...

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to all...

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Lofexidine is an experimental medication that may be beneficial in reducing opiate withdrawal symptoms, such as sleep difficulty, anxiety, and tension. The purpose of this study is to det...

Lofexidine for Opiate Withdrawal - 1

The purpose of this study is to evaluate lofexidine for opiate withdrawal.

Lofexidine's Impact on Stress and Opiate Use

Individuals with opioid use disorder who are stabilized on buprenorphine will be randomly assigned to receive placebo or lofexidine for 5 weeks. At the end of five weeks, they will complet...

PubMed Articles [14809 Associated PubMed Articles listed on BioPortfolio]

Lofexidine (Lucemyra) for opioid withdrawal.

Integration of Medication-Assisted Treatment Information for Opioid Use Disorders Into a Graduate Nursing Curriculum.

The United States is in the midst of an unprecedented public health crisis, with annual morbidity and mortality data related to opioid use consistently increasing and appearing more worrisome. To miti...

Treatment Options for Opioid Use Disorders: A Review of the Relevant Literature.

Approximately 10% of the 20 million Americans who are suffering from substance use disorders are suffering from prescription opioid and heroine misuse. This has led to a rise in overdoses as well as e...

POFA trial study protocol: a multicentre, double-blind, randomised, controlled clinical trial comparing opioid-free versus opioid anaesthesia on postoperative opioid-related adverse events after major or intermediate non-cardiac surgery.

Reducing opioid consumption during and after surgery has been recommended for more than 10 years. Opioid-free anaesthesia (OFA) is a multimodal anaesthesia associating hypnotics, NMDA antagonists, loc...

Dynorphin / Kappa-opioid receptor control of dopamine dynamics: implications for negative affective states and psychiatric disorders.

Negative affective states are prevalent symptoms in a plethora of neuropsychiatric disorders, including depression and drug addiction. Dysfunction of mesocorticolimbic dopamine systems has been implic...

Medical and Biotech [MESH] Definitions

Disorders related or resulting from abuse or mis-use of opioids.

These disorders are related to both SCHIZOPHRENIA SPECTRUM AND RELATED DISORDERS and DEPRESSIVE DISORDERS in terms of symptomatology, family history, and genetics. (DSM-V) .

Disorders related to substance abuse, the side effects of a medication, toxin exposure, and ALCOHOL-RELATED DISORDERS.

A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. It also has a depressant action on the cough center and may be given to control intractable cough associated with terminal lung cancer. Methadone is also used as part of the treatment of dependence on opioid drugs, although prolonged use of methadone itself may result in dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)

Agents that induce NARCOSIS. This term is considered outdated due to imprecision but continues to be widely used. Originally, agents that caused somnolence or induced sleep (STUPOR); now, any derivative, natural or synthetic, of OPIUM or MORPHINE or any substance that has their effects. Narcotics are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS.

More From BioPortfolio on "Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Searches Linking to this Trial